Skip to main content
Glama

Snb Ch

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare read-only and idempotent behavior; the description adds substantial context beyond them: graceful degradation of LEI/FIGI enrichment, explicit unresolved identifier reporting, candidate-return behavior for ambiguous matches, and the fact that each call cascades through multiple endpoints. This is far more than annotations alone provide.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but highly information-dense, with front-loaded usage guidance followed by per-type details and caveats. It is somewhat dense in the middle, but every sentence contributes to disambiguating a genuinely complex tool, so the length is justified.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema and no per-parameter documentation beyond basic descriptions, the description carries full responsibility — and it delivers. It covers supported types, input formats, resolution behavior, ambiguity handling, enrichment fallbacks, and identifier sources, so an agent has enough context to call the tool correctly in nearly all cases.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Even though schema coverage is 100%, the description adds critical meaning beyond the schema: value should be the entity name only, bond lookups require the exact issuer as printed, trailing security-class words will match nothing, and an ISIN input resolves to the legal-entity issuer. These examples and caveats materially improve correct invocation.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a precise verb+resource pair: resolving user-spoken names to canonical/official identifiers. It is clearly distinct from sibling tools like entity_profile and compare_entities by positioning itself as the required first step whenever a tool input needs an ID.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicit guidance appears up front: 'Use FIRST whenever you have a name but need an ID.' The description also gives example user queries and clarifies when ambiguity should be resolved by returning figi_candidates, but it does not explicitly name alternatives or when-not-to-use cases.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Snb Ch toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.9/5.0
Disambiguation3/5

Several tools serve overlapping purposes: ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded, deep_research, validate_claim, and suggest_questions all handle question-answering, with beta currently identical to the main router. The Polymarket family has six distinct but related tools, and descriptions are detailed enough to differentiate, but an agent could still misselect when the boundaries are subtle.

Naming Consistency3/5

All tool names use snake_case, but the pattern is mixed: some start with verbs (resolve_entity, validate_claim), while many are noun phrases (entity_profile, bet_research, polymarket_edges). This is readable but not a consistent verb_noun convention, and the repeated ask_pipeworx_* and polymarket_* prefixes add some structure.

Tool Count2/5

At 33 tools, the surface is heavy for an agent to navigate. While the server covers a broad data-research and prediction-market domain, the count exceeds what is typically manageable, and several tools (ask_pipeworx_beta, discover_tools) could be collapsed or merged without losing core capability.

Completeness4/5

The tool set covers the domain well: querying, grounded verification, entity profiles, comparisons, prediction-market analysis, subscriptions, memory, and onboarding. Minor gaps exist (e.g., no tool to fetch a full SEC filing body directly, relying on ask_pipeworx routing), but there are no obvious dead ends for the stated purposes.

Resources